C (ECS 2000-2009)

CBR-CB1 CANNABINOID RECEPTOR (Activated by THC, Anandamide, Synthetics, Activating CB1 Receptors in the Brain Causes the ‘High’)
CBR-CB2 CANNABINOID RECEPTOR (No ‘High’, Activated by THC, Anandamide, 2-AG, THC)
CBR-CBe (Endothelial Cannabinoid Receptor)
CBR-GPR18 / CANNABINOID RECEPTOR (Activated by Abnormal CBD, NAGly, O-1602, THC, Anandamide)
CBR-GPR40 / CANNABINOID RECEPTOR / FFAR1 (Activated by GW1100, TAK-875)
CBR-GPR55 / CB3 CANNABINOID RECEPTOR (Activated by l-α-lysophosphatidylinositol [LPI] and to a lesser extent possibly by THC, CBD,O-1602, PEA, 2-AG, Anandamide, Virodhamine)
CBR-GPR119 / CANNABINOID RECEPTOR *(Activated by PEA, OEA)
CBR-GPR158 / CANNABINOID RECEPTOR


CBR-CB1 CANNABINOID RECEPTOR
Cannabinoid Receptor Ligands (full–undated) http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html
Endocannabinoids and Vascular Function (full–2000) http://jpet.aspetjournals.org/content/294/1/27.long
Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human (full–2000) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1571997/?tool=pmcentrez
Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea-pig ileum (full-2000) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1571902&tool=pmcentrez
2-Arachidonoylglycerol and the cannabinoid receptors (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11106784
Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats (abst–2000) http://www.springerlink.com/content/w3jc8rk16k9p92fl/
Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats (abst–2000) http://www.sciencedirect.com/science/article/pii/S0014299900008438
Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10733937
Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11204352
Are Cannabinoid Receptor Knockout Mice Animal Models for Schizophrenia? (abst-2000) http://www.medical-hypotheses.com/article/S0306-9877%2800%2991261-1/abstract
CB1 cannabinoid receptor expression in brain regions associated with zebra finch song control (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10700562
SCIENTIFIC STUDY HINTS AT MEDICAL BENEFITS IN CANNABINOIDS AND MULTIPLE SCLEROSIS (news–2000) http://www.alphagalileo.org/ViewItem.aspx?ItemId=52315&CultureCode=en
Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A (full–2001) http://www.nature.com/npp/journal/v24/n2/full/1395605a.html
The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2 (full–2001) http://www.nature.com/npp/journal/v24/n2/full/1395605a.html
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572987/?tool=pmcentrez
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full–2001) http://content.onlinejacc.org/cgi/content/full/38/7/2048?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=560&resourcetype=HWCIT
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC31108/
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC55427/?tool=pubmed
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572991/?tool=pubmed
The neurobiology and evolution of cannabinoid signalling (full–2001) http://rstb.royalsocietypublishing.org/content/356/1407/381.full.pdf+html
The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11394887
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid (full–2002) http://www.eje-online.org/content/147/2/255.full.pdf+html
Sourcing the Code: Searching for the Evolutionary Origins of Cannabinoid Receptors, Vanilloid Receptors, and Anandamide (full–2002) http://www.cannabis-med.org/data/pdf/2002-01-3.pdf
A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding (full-2002) http://www.jneurosci.org/content/22/21/9612.full
Influence of the CB1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats (full–2002) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573379/?tool=pmcentrez
Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice (full – 2002) http://www.jneurosci.org/cgi/content/full/22/22/9771?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&resourcetype=HWCIT#Top
Cannabinoid CB1 receptor as a target for chlorpyrifos oxon and other organophosphorus pesticides (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12243867
Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington’s disease (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12709298
N-Acylethanolamines in human reproductive fluids (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505702
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12395075
The endogenous cannabinoid system controls extinction of aversive memories (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12152079
Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/11841893
Marijuana receptor gene abnormality in schizophrenia (news–2002) http://www.eurekalert.org/pub_releases/2002-07/mp-mrg061802.php
Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells (full–2003) http://www.jimmunol.org/content/170/10/4953.full?sid=590f7819-f39b-4214-abca-07231b51da55
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction (full-2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573770/?tool=pmcentrez
Endocannabinoid signalling in the blood of patients with schizophrenia (full–2003) http://www.lipidworld.com/content/2/1/5
The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy (full–2003) http://jpet.aspetjournals.org/content/307/1/129.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC166293/
Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets (full–2003) http://jp.physoc.org/content/550/1/149.full
Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon (full–2003) http://ajpgi.physiology.org/content/286/1/G110.full?sid=fc6948f0-78cf-405c-981b-afaa05ee417c
Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients (full–2003) http://www.nature.com/mp/journal/v8/n5/full/4001278a.html
Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis1 (full-2003) http://www.fasebj.org/cgi/reprint/17/12/1771
High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12970790
Cannabinoid receptor type 1 (CB1) affects hypothalamic-pituitary-adrenal (HPA) axis activity at cerebral and pituitary level (abst–2003) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2003-817562
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12505538
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a “CB3” receptor (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12568912
Expression of functionally active cannabinoid receptor CB1 in the human prostate gland (abst–2003) http://onlinelibrary.wiley.com/doi/10.1002/pros.10165/abstract
Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/14746372?dopt=Abstract
Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271 (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/14519516
Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington’s disease transgenic mice (full–2004) http://onlinelibrary.wiley.com/doi/10.1111/j.1432-1033.2004.04460.x/full
Presynaptic cannabinoid CB1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575049/?tool=pmcentrez
Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice (full–2004) http://molpharm.aspetjournals.org/content/66/2/204.long
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity (full–2004) http://www.nature.com/ijo/journal/v28/n4/full/0802583a.html
Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse (full–2004) http://www.nature.com/mp/journal/v9/n10/full/4001560a.html
Endogenous Cannabinoids Take the Edge off Neuroendocrine Responses to Stress (full–2004) http://press.endocrine.org/doi/full/10.1210/en.2004-1218
Evidence for an Interaction between CB1 Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake (full–2004) http://press.endocrine.org/doi/full/10.1210/en.2004-0059
The endocannabinoid system: physiology and pharmacology (full–2004) http://alcalc.oxfordjournals.org/cgi/content/full/40/1/2
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574972/
SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1Hpyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization (full–2004) http://jpet.aspetjournals.org/content/310/3/905.long
Delayed onset of Huntington’s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14667455
Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene (abst-2004) http://www.ncbi.nlm.nih.gov/pubmed/15108190
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15640759
[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15110734
TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid Narachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15245490
Cb(1) Receptor Mediation of Cannabinoid Behavioral Effects in Male and Female Rats (abst-2004) http://www.ncbi.nlm.nih.gov/pubmed/14991224
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice (abst–2004) http://onlinelibrary.wiley.com/doi/10.1111/j.1460-9568.2004.03293.x/abstract;jsessionid=15C92BB3498FAF0EE40394675E8B1800.d01t01
Overeating, Alcohol and Sucrose Consumption Decrease in Cb1 Receptor Deleted Mice. (abst – 2004) http://www.ncbi.nlm.nih.gov/pubmed/12770700
Cannabinoids spell relief in colon inflammation (news–2004) http://www.mpg.de/496761/pressRelease20040506?filter_order=L
On the Cannabinoid Receptor: A Study in Molecular Psychiatry (full–2005) (needs free registration) http://www.psychiatrictimes.com/articles/cannabinoid-receptor-study-molecular-psychiatry
Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear (full-2005) http://www.nature.com/npp/journal/v30/n3/full/1300655a.html
Depression in Parkinson’s disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1) (full–2005) http://www.nature.com/tpj/journal/v5/n2/full/6500301a.html
Role of the endocannabinoid system in the development of tolerance to alcohol (full–2005) http://alcalc.oxfordjournals.org/content/40/1/15.long
Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central Amygdala (full–2005) http://www.nature.com/npp/journal/v30/n3/full/1300535a.html
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087161/?tool=pmcentrez
The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis (full-2005) https://www.jstage.jst.go.jp/article/tjem/207/2/207_2_99/_pdf
CB1 cannabinoid receptor-mediated modulation of food intake in mice (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576140/?tool=pmcentrez
Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751228/?tool=pubmed
Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1266095/?tool=pubmed
Antidepressant-like Activity and Modulation of Brain Monoaminergic Transmission by Blockade of Anandamide Hydrolysis (full–2005) http://www.pnas.org/content/102/51/18620.long
Ethanol Induces Higher Bec in Cb1 Cannabinoid Receptor Knockout Mice While Decreasing Ethanol Preference (full–2005) http://alcalc.oxfordjournals.org/content/40/1/54.long
Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors (full–2005) http://gut.bmj.com/content/54/4/522.full?sid=0731f0e5-2071-4549-be57-57f444307138
The endocannabinoid system drives neural progenitor proliferation (full–2005) http://www.fasebj.org/content/early/2005/09/30/fj.05-3995fje.long
Analgesia through endogenous cannabinoids (full–2005) http://www.cmaj.ca/cgi/content/full/173/4/357?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=endocannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT
Direct cerebrovascular effects of CB1 receptor activation by the synthetic endocannabinoid HU-210 in vivo (abst–2005) http://www.nature.com/jcbfm/journal/v25/n1s/full/9591524.0581a.html
Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat (abst–2005) http://www.sciencedirect.com/science/article/pii/S0014299905003870
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors (abst–2005) http://www.sciencedirect.com/science/article/pii/S0014299905013178
The Endogenous Cannabinoid System. Therapeutic Implications for Neurologic and Psychiatric Disorders (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15776259
Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15927811
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15953683
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15588725
Finding of endocannabinoids in human eye tissues: implications for glaucoma (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15823551
Cannabinoids and ceramide: two lipids acting hand-by-hand (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15958274
Treatment of Tourette-syndrome with cannabinoids: results from clinical and neuroimaging studies (abst–2005) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2005-918789
Marijuana May Grow Neurons in the Brain (news–2005) http://www.medpagetoday.com/Psychiatry/AnxietyStress/1934
The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769341/?tool=pmcentrez
AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1615836/?tool=pmcentrez
Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus (full–2006) http://jpet.aspetjournals.org/content/317/3/1072.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#ref-list-1
Activation of G-proteins in brain by endogenous and exogenous cannabinoids (full–2006) http://www.ncbi.nlm.nih.gov/pubmed/16584117
The Cannabinoid Cb1 Receptor Antagonist Rimonabant Attenuates the Hypotensive Effect of Smoked Marijuana in Male Smokers (full–2006) http://www.ahjonline.com/article/S0002-8703%2805%2901013-6/fulltext
Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons (full–2006) http://jpet.aspetjournals.org/content/320/1/64.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=3680&resourcetype=HWCIT
Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1808496/?tool=pmcentrez
Antinociceptive effect of cannabinoid agonist WIN 55,212–2 in rats with a spinal cord injury (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1861843/?tool=pmcentrez
Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl] ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor (full–2006) http://molpharm.aspetjournals.org/content/70/1/41.long
Involvement of Neuronal Cannabinoid Receptor CB1 in Regulation of Bone Mass and Bone Remodeling (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238031/?tool=pmcentrez
Cannabinoid CB1 Receptor Mediates Fear Extinction via Habituation-Like Processes (full–2006) http://www.jneurosci.org/cgi/content/full/26/25/6677?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=400&resourcetype=HWCIT
Cannabinoid receptors in human astroglial tumors (full–2006) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2006.03911.x/pdf
(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population (full–2006) http://www.nature.com/tpj/journal/v6/n2/full/6500352a.html
Evolutionary Origins of the Endocannabinoid System (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16434153
Neuromodulatory functions of the endocannabinoid system (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16751707
Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16953388
Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16787257
Science: Cannabinoids reduce inflammation of the bowel in animal model (news–2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=216#1
PET imaging of cerebral cannabinoid CB1 receptors with [11C]JHU75528 (news–2006) http://www.news-medical.net/news/2006/06/06/18312.aspx
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling (full-2007) http://www.fasebj.org/cgi/content/full/22/1/285
The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport (full–2007) http://jpet.aspetjournals.org/content/321/1/370.full
Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms (full–2007) http://journals.tums.ac.ir/upload_files/pdf/_/6670.pdf
Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner (full–2007) http://www.jbc.org/content/283/10/6005.full?sid=931583b1-e797-43e0-8296-7fd75bb49403#sec-4
CANNABINOID-INDUCED HYPERPHAGIA: CORRELATION WITH INHIBITION OF PROOPIOMELANOCORTIN NEURONS? (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720321/?tool=pmcentrez
Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men (full–2007) http://jcem.endojournals.org/content/92/6/2382.long
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234438/
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis (full-2007) http://www.jbc.org/content/282/33/23892.full
Expression of Cannabinoid CB1 Receptors in Models of Diabetic Neuropathy (full–2007) http://jpet.aspetjournals.org/content/323/2/508.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT
Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Subtypes in Human Multiple Sclerosis (full–2007) http://www.jneurosci.org/cgi/content/full/27/9/2396?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
Cannabinoid action in the olfactory epithelium (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1815290/?tool=pmcentrez
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson’s disease: role of CB1 and TRPV1 receptors (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2128772/?tool=pmcentrez
Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189718/?tool=pubmed
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190006/?tool=pmcentrez
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro (full–2007) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2189767&tool=pmcentrez
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042924/?tool=pubmed
CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distensioninduced visceral pain in rodents (full–2007) http://www.jneurosci.org/content/29/5/1554.long
Hemopressin is an inverse agonist of CB1 cannabinoid receptors (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2154475/
The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells (full-2007) http://onlinelibrary.wiley.com/doi/10.1002/ijc.22917/pdf
Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013996/
BfCBR: a cannabinoid receptor ortholog in the cephalochordate Branchiostoma floridae (Amphioxus) (abst–2007) http://www.frontiersin.org/publications/17553639
Effect of Endocannabinoid System on the Neurogenic Function of Rat Corpus Cavernosum (abst–2007) http://rjms.iums.ac.ir/browse.php?a_code=A-10-1-760&sid=1&slc_lang=en
Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open field behavior in rats (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17912052
Repeated Treatment with Cannabidiol but Not Delta9-tetrahydrocannabinol Has a Neuroprotective Effect Without the Development of Tolerance (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17320118
The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors (abst–2007) http://www.sciencedirect.com/science/article/pii/S0014299907007935
Immune-mediated Activation of the Endocannabinoid System in Visceral Adipose Tissue in Obesity (abst–2007) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2007-984459
Pharmacological analysis of cannabinoid-induced inhibition of gastric mucosal damage and gastric motility (abst–2007) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2007-982722
Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17507169
In Vitro Anticonvulsant Action of 2-Arachidonyl Glycerol (abst–2007) http://jkaumedsci.sa/kau/index.php/jkaumedsci/article/view/165
The endocannabinoid system and neurogenesis in health and disease (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17404371
Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17459108
No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17292652
Hippies vindicated: Human-produced cannabinoids have anti-inflammatory powers (news–2007) http://www.sciencecodex.com/hippies_vindicated_human_produced_cannabinoids_have_anti_inflammatory_powers
Neural Substrates Underlying the Effects of Cannabinoids, and More (news–2007) http://www.alphagalileo.org/ViewItem.aspx?ItemId=11623&CultureCode=en
The Endocannabinoids: Functional Roles and Therapeutic Opportunities (news–2007) http://www.alphagalileo.org/ViewItem.aspx?ItemId=11344&CultureCode=en
Whole-Body Biodistribution and Radiation Dosimetry of the Human Cannabinoid Type-1 Receptor Ligand ^sup 18^F-MK-9470 in Healthy Subjects (full–2008) http://jnm.snmjournals.org/content/49/3/439.long
Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations (full–2008) http://hmg.oxfordjournals.org/content/17/13/1916.long
Cannabinoid Receptor 1 Gene Association With Nicotine Dependence (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733353/
Role of endocannabinoids in cardiovascular shock (full–2008) http://www.jpp.krakow.pl/journal/archive/12_08_s8/pdf/91_12_08_s8_article.pdf
Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685476/?tool=pubmed
Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577828/
The cannabinoid CB1 receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577903/?tool=pmcentrez
Cannabinoid Modulation of Cutaneous A{delta} Nociceptors During Inflammation (full-2008) http://jn.physiology.org/cgi/reprint/100/5/2794
Topical WIN55212-2 Alleviates Intraocular Hypertension in Rats Through a CB1 Receptor-Mediated Mechanism of Action (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637200/?tool=pmcentrez
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/
Loss of Cannabinoid Receptor CB1 Induces Preterm Birth (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553193/?tool=pmcentrez
Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219536/?tool=pmcentrez
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation (full–2008) http://onlinelibrary.wiley.com/doi/10.1002/ijc.23584/full
Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991137/
Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity (full-2008) http://content.onlinejacc.org/cgi/content/full/50/6/528
Cannabinoid receptors and the regulation of bone mass (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219540/?tool=pmcentrez
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2561258/?tool=pubmed
Cannabinoid CB1 Receptors Are Expressed by Parietal Cells of the Human Gastric Mucosa (full–2008) http://jhc.sagepub.com/content/56/5/511.full
Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages (full–2008) http://cardiovascres.oxfordjournals.org/content/81/4/805.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Expression of the Endocannabinoid System in Human First Trimester Placenta and Its Role in Trophoblast Proliferation (full–2008) http://endo.endojournals.org/content/149/10/5052.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8
Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659532/
Feeding induced by cannabinoids is mediated independently of the melanocortin system (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386290/?tool=pubmed
Design Logic of a Cannabinoid Receptor Signaling Network That Triggers Neurite Outgrowth (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776723/?tool=pubmed
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2561258/
An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694060/
Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2008.00258.x/full
Cannabinoids and gastrointestinal motility: animal and human studies (link to PDF-2008) http://www.europeanreview.org/article/519
The role of the CB1 receptor in the regulation of sleep (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
The modulatory role of endocannabinoids in sleep (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18297624
Peripheral cannabinoid CB1 receptors inhibit evoked responses of nociceptive neurones in vivo (abst–2008) http://www.sciencedirect.com/science/article/pii/S0014299908002719
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18077184
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18204441
Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716) (abst–2008) http://www.frontiersin.org/publications/18654765
The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons (abst–2008) http://www.frontiersin.org/publications/17931621
Dysregulation of the endocannabinoid system in obesity (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18426509
Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population (abst–2008) http://iospress.metapress.com/content/p42u458n7608461g/?p=ff122a13e6cf4bf78324e26d253bd883&pi=5
Effect of anandamide in improving of the non-adrenergic non-cholinergic relaxation of the corpus cavernosum from diabetic rats (abst–2008) http://journals.tums.ac.ir/abs.aspx?org_id=59&culture_var=en&journal_id=9&issue_id=1415&manuscript_id=12280&segment=fa
Effect of biliary cirrhosis on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum: Role of nitric oxide pathway and endocannabinoid system (abst–2008) http://journals.tums.ac.ir/abs.aspx?culture_var=en&journal_id=9&org_id=59&manuscript_id=6272
Presence of functional cannabinoid receptors in human endocrine pancreas (abst–2008) http://www.frontiersin.org/publications/18092149
High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18615640
Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18938775
Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18579347
Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18186055
Evaluation of Delta9 -Tetrahydrocannabinoland other Cannabinoids for Antidepressant-like Actions in the Mouse Forced Swim Test (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2008-1075224
Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18485596?dopt=Abstract&holding=f1000,f1000m,isrctn
Turned-Off Cannabinoid Receptor Turns On Colorectal Tumor Growth (news-2008) http://www.sciencedaily.com/releases/2008/08/080801074056.htm
Cannabinoid cell surface receptor plays a tumor-suppressing role in human colorectal cancer (news–2008) http://www.news-medical.net/news/2008/08/03/40485.aspx
Marijuana takes on colon cancer (news–2008) http://www.newscientist.com/article/dn14451-marijuana-takes-on-colon-cancer.html?DCMP=ILChmts&nsref=news9_head_dn14451#.Usie9rRhX5M
Opioids and cannabinoids influence mobility of spermatozoids (news–2008) http://www.alphagalileo.org/ViewItem.aspx?ItemId=5296&CultureCode=en
Actions of delta-9-tetrahydrocannabinol in cannabis (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731700/?tool=pmcentrez
Cannabinoid Receptor 1 Binding Activity and Quantitative Analysis of Cannabis sativa L. Smoke and Vapor (full–2009) https://www.jstage.jst.go.jp/article/cpb/58/2/58_2_201/_pdf
Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660732/?tool=pmcentrez
The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757501/
Endocannabinoid-mediated control of synaptic transmission (full–2009) http://physrev.physiology.org/content/89/1/309.long
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688760/?tool=pubmed
Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon (full–2009) http://ajpgi.physiology.org/cgi/content/full/296/1/G119?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT
Characterization of the Endocannabinoid System in Human Neuronal Cells and Proteomic Analysis of Anandamide-induced Apoptosis (full–2009) http://www.jbc.org/content/284/43/29413.full
Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma (full-2009) http://mct.aacrjournals.org/content/8/7/1838.full
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity (full–2009) http://brain.oxfordjournals.org/content/132/11/3152.long
Type 1 Cannabinoid Receptor-Containing Axons Innervate Hypophysiotropic Thyrotropin-Releasing Hormone-Synthesizing Neurons (full–2009) http://endo.endojournals.org/content/150/1/98.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8
Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats (full–2009) http://www.if-pan.krakow.pl/pjp/pdf/2009/2_304.pdf
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055381/?tool=pubmed
Relationship of type 1 cannabinoid receptor availability in the human brain to novelty seeking temperament (full–2009) http://archpsyc.ama-assn.org/cgi/content/full/66/2/196
Dose Dependent effects of Celecoxib on CB-1 Agonist Induced Antinociception in mice (full–2009) http://journals.tums.ac.ir/upload_files/pdf/_/14234.pdf
CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages (full–2009) http://cardiovascres.oxfordjournals.org/content/84/3/378.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work? (full–2009) http://cardiovascres.oxfordjournals.org/content/84/3/341.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development (full–2009) http://www.rbej.com/content/7/1/121
Anandamide injected into the lateral ventricle of the brain inhibits submandibular salivary secretion by attenuating parasympathetic neurotransmission (full–2009) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000600010&lng=en&nrm=iso
Unconventional neurotransmitters, neurodegeneration and neuroprotection (full–2009) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000100011&lng=en&nrm=iso
Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions (full–2009) http://www.nature.com/ijo/journal/v33/n9/full/ijo2009132a.html
Novel endogenous peptide agonists of cannabinoid receptors (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735371/
The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation (full–2009) http://www.nature.com/ijo/journal/v33/n2s/full/ijo200967a.html
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization induced suppression of excitation in autaptic hippocampal neurons (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784730/
Chronic stress differentially regulates cannabinoid CB1 receptor binding in distinct hippocampal subfields (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746437/
The endocannabinoid system as a target for the treatment of motor dysfunction (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697699/
Processing cardiovascular information in the vlPAG during electroacupuncture in rats: roles of endocannabinoids and GABA (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692771/#!po=4.54545
Impairments in Endocannabinoid Signaling and Depressive Illness (abst + 1st page–2009) http://jama.jamanetwork.com/article.aspx?articleid=183558
Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19897083
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas (abst–2009) http://www.sciencedirect.com/science/article/pii/S0006899308030588
Variations in the cannabinoid receptor 1 gene predispose to migraine (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19539700
The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi’s sarcoma cells in vitro (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19539619
Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19399401
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington’s disease (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19524019
Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19580839
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects (abst–2009) http://www.frontiersin.org/publications/19027757
Neurobiology and Systems Physiology of the Endocannabinoid System (abst–2009) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1216346
Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19607846
Mode of action of cannabinoids on nociceptive nerve endings (abst–2009) http://www.frontiersin.org/publications/19306092
The cannabinoid system: cannabinoids and receptors (news–2009) http://www.examiner.com/health-science-in-vancouver/the-cannabinoid-system-cannabinoids-andreceptors
top


CBR-CB2 CANNABINOID RECEPTOR
Cannabinoid Receptor Ligands (full–undated) http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html
2-Arachidonoylglycerol and the cannabinoid receptors (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11106784
Immunomodulation by Cannabinoids is Absent in Mice Deficient for the Cannabinoid Cb(2) Receptor (abst–2000) http://www.sciencedirect.com/science/article/pii/S0014299900002119
Involvement of central and peripheral cannabinoid receptors in the regulation of heart resistance to arrhythmogenic effects of epinephrine (abst–2000) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11182823&dopt=abstractplus
SCIENTIFIC STUDY HINTS AT MEDICAL BENEFITS IN CANNABINOIDS AND MULTIPLE SCLEROSIS. (news–2000) http://www.alphagalileo.org/ViewItem.aspx?ItemId=52315&CultureCode=en
Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor1 (full-2001) http://cancerres.aacrjournals.org/cgi/reprint/61/15/5784.pdf
Sourcing the Code: Searching for the Evolutionary Origins of Cannabinoid Receptors, Vanilloid Receptors, and Anandamide (full–2002) http://www.cannabis-med.org/data/pdf/2002-01-3.pdf
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (full–2002) http://bloodjournal.hematologylibrary.org/cgi/content/full/100/2/627?ijkey=eb71d6d7a06f311440761cfac6a7d081bcc2771d
Evolution of Cannabinoid Receptors in Vertebrates: Identification of a CB2 Gene in the Puffer Fish Fugu rubripes (full–2002) http://www.biolbull.org/content/202/2/104.long
CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12550743
Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12227101
Lymphoma may be slowed by cannabis (news–2002) http://marijuana-ro.com/medical-usage/lymphoma-may-be-slowed-by-cannabis.html
Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells (full–2003) http://www.jimmunol.org/content/170/10/4953.full?sid=590f7819-f39b-4214-abca-07231b51da55
Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer’s Disease Brains (full–2003) http://www.jneurosci.org/content/23/35/11136.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&resourcetype=HWCIT
Endocannabinoid signalling in the blood of patients with schizophrenia (full–2003) http://www.lipidworld.com/content/2/1/5
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS (full–2003) http://www.pnas.org/content/100/18/10529.full
Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors (full–2003) http://journals.lww.com/anesthesiology/Fulltext/2003/10000/Inhibition_of_Inflammatory_Hyperalgesia_by.31.aspx
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN (full–2003) http://www.jleukbio.org/cgi/content/full/75/3/453?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT
Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guineapigs by cannabinoid (CB2) receptor activation (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574031/?tool=pubmed
Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12921861
Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575196/?tool=pmcentrez
Cannabinoids and intestinal motility: welcome to CB2 receptors (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1575197/
The Peripheral Cannabinoid Receptor CB2 and CD40 Are Novel Biological Markers That Predict Outcome in Diffuse Large B-Cell Lymphoma of Elderly Patients (abst–2004) http://abstracts.hematologylibrary.org/cgi/content/abstract/104/11/3256?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=800&resourcetype=HWCIT
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors (abst-2004) http://www.ncbi.nlm.nih.gov/pubmed/15556131
Cannabinoid receptor type 2 gene is associated with human osteoporosis (full–2005) http://hmg.oxfordjournals.org/cgi/content/full/14/22/3389?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=400&resourcetype=HWCIT
Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders (full–2005) http://www.jleukbio.org/content/78/1/231.long
Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751228/?tool=pubmed
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor independent mechanism (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089/?tool=pmcentrez
CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility (full–2005) http://www.iovs.org/content/46/6/1988.long
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice (full-2005) http://www.nature.com/nature/journal/v434/n7034/full/nature03389.html
p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells (full–2005) http://www.sciencedirect.com/science/article/pii/S0014579305010057
Identification and functional characterization of brainstem cannabinoid CB2 receptors. (full – 2005) (requires free registration) http://www.sciencemag.org/content/310/5746/329.full
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation (link to PDF–2005) http://www.springerlink.com/content/tq777102q4185073/fulltext.html
Chemical modification of the naphthoyl 3-position of JWH-015: In search of a fluorescent probe to the cannabinoid CB2 receptor (abst–2005) http://www.sciencedirect.com/science/article/pii/S0960894X05006803
Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15927811
The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16142631
Marijuana May Grow Neurons in the Brain (news–2005) http://www.medpagetoday.com/Psychiatry/AnxietyStress/1934
The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435344/?tool=pmcentrez
Alkylamides from Echinacea Are a New Class of Cannabinomimetics (full–2006) http://www.jbc.org/content/281/20/14192.full
Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 Expression (full–2006) http://molpharm.aspetjournals.org/content/70/3/897.long
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation (full – 2006) http://www.fasebj.org/cgi/content/full/20/13/2405?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013801/?tool=pubmed
Peripheral cannabinoid receptor, CB2, regulates bone mass (full–2006) http://www.pnas.org/content/103/3/696.full
Signaling pathways involved in the cardioprotective effects of cannabinoids (full-2006) https://www.jstage.jst.go.jp/article/jphs/102/2/102_2_155/_pdf
Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects (full–2006) http://www.jbc.org/content/281/20/14192.long
Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice (full–2006) http://www.jimmunol.org/content/177/12/8796.full
New Natural Noncannabinoid Ligands for Cannabinoid Type-2 (CB2) Receptors (abst-2006) http://informahealthcare.com/doi/abs/10.1080/10799890600942674
Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production (abst–2006) http://www.ingentaconnect.com/content/klu/mcbi/2006/00000283/F0020001/00002346
Evolutionary Origins of the Endocannabinoid System (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16434153
Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/19804131
The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16624285
Formation of B and T cell subsets require the cannabinoid receptor CB2 (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16924491
Activation of CB2 receptor attenuates bone loss in osteoporosis (news–2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=210#2
Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis (full–2007) http://www.jneurosci.org/cgi/content/full/27/9/2396?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219542/?tool=pmcentrez
Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision (full–2007) http://journals.lww.com/anesthesiology/Fulltext/2007/04000/Spinal_Cannabinoid_Receptor_Type_2_Activation.21.aspx
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/?tool=pmcentrez
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/?tool=pmcentrez
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042924/?tool=pubmed
Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637559/?tool=pmcentrez
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819701/?tool=pmcentrez
CB2 receptors in the brain: role in central immune function (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219530/?tool=pmcentrez
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/?tool=pmcentrez
Potential role for CB2 selective ligands as immunosuppressive agents (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1864948/?tool=pmcentrez
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219541/?tool=pmcentrez
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro (full–2007) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2189767&tool=pmcentrez
CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension induced visceral pain in rodents (full–2007) http://www.jneurosci.org/content/29/5/1554.long
BfCBR: a cannabinoid receptor ortholog in the cephalochordate Branchiostoma floridae (Amphioxus) (abst–2007) http://www.frontiersin.org/publications/17553639
Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/18038967
CB2 cannabinoid receptors promote mouse neural stem cell proliferation (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17328768
Comparison Analysis of Gene Expression Patterns between Sporadic Alzheimer’s and Parkinson’s Disease (abst–2007) http://iospress.metapress.com/content/336t86725725564t/?p=00368d67a25c414b9e1ecc38b534bdfc&pi=10
The Role of Alkamides as an Active Principle of Echinacea (abst–2007) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2007-981531
Cannabinoids for the treatment of inflammation (abst–2007) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=17520866&dopt=abstractplus
Cannabinoid CB2 receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17643417
The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors (abst–2007) http://www.sciencedirect.com/science/article/pii/S0014299907007935
Role of cannabinoid CB2 receptors in glucose homeostasis in rats (abst–2007) http://www.sciencedirect.com/science/article/pii/S001429990700249X
The cannabinoid CB(2) receptor: a good friend in the gut (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17727390
Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17189959
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17205329
Hippies vindicated: Human-produced cannabinoids have anti-inflammatory powers (news–2007) http://www.sciencecodex.com/hippies_vindicated_human_produced_cannabinoids_have_anti_inflammatory_powers
The Endocannabinoids: Functional Roles and Therapeutic Opportunities (news–2007) http://www.alphagalileo.org/ViewItem.aspx?ItemId=11344&CultureCode=en
CB2 receptors in reproduction (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219526/
Cannabinoid CB2 receptors in human brain inflammation (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219537/
Selective CB2 up-regulation in women affected by endometrial inflammation (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2007.00085.x/full
In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints (full–2008) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2219539&tool=pmcentrez
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling (full–2008) http://www.fasebj.org/content/22/10/3685.long
Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592089/?tool=pmcentrez
Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor (full–2008) http://press.endocrine.org/doi/full/10.1210/en.2008-0150
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/
The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking INVOLVEMENT IN THE PATHOGENESIS OF AN ANIMAL MODEL OF MULTIPLE SCLEROSIS (full-2008) http://www.jbc.org/content/283/19/13320.long
Cannabinoid receptors and the regulation of bone mass (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219540/?tool=pmcentrez
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats (full-2008) http://jpet.aspetjournals.org/content/327/2/584.full#content-block
Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267750/?tool=pubmed
Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain (full–2008) http://www.jneurosci.org/cgi/content/full/28/46/12125
Expression of the Endocannabinoid System in Human First Trimester Placenta and Its Role in Trophoblast Proliferation (full–2008) http://endo.endojournals.org/content/149/10/5052.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8
The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677557/
Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494728/?tool=pubmed
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219529/?tool=pubmed
Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376822/?tool=pmcentrez
Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats (full–2008) http://jpet.aspetjournals.org/content/324/2/475.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#content-block
Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219536/?tool=pmcentrez
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product (full–2008) http://www.ncbi.nlm.nih.gov/pubmed/18806815
Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577828/
CB2 receptors as new therapeutic targets for liver diseases (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219531/?tool=pubmed
The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis (full–2008) http://www.jbc.org/content/283/19/13320.long
Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain (full-2008) http://www.jneurosci.org/cgi/content/full/28/46/12125
Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages (full–2008) http://cardiovascres.oxfordjournals.org/content/81/4/805.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling (full–2008) http://www.fasebj.org/content/22/10/3685.long
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation (full-2008) http://onlinelibrary.wiley.com/doi/10.1002/ijc.23584/full
Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2008.00258.x/full
MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597252/
Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain (abst–2008) http://www.sciencedirect.com/science/article/pii/S0014299908000630
Role of CB2 receptors in neuroprotective effects of cannabinoids (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18291574
Presence of functional cannabinoid receptors in human endocrine pancreas (abst–2008) http://www.frontiersin.org/publications/18092149
Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18991890
Discovery of a novel cannabinoid in food (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0028-1083900
Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down’s syndrome (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18068305
Immunomodulatory Lipids in Plants: Plant Fatty Acid Amides and the Human Endocannabinoid System (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2008-1034302
Analgesic and neuropsychological effects of Echinacea N-alkylamides (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0028-1084300
Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/17675107
New Cannabis-Like Drugs Could Block Pain Without Affecting Brain, Says Study (news-2008) http://www.sciencedaily.com/releases/2008/09/080912091728.htm
Cannabislike Drugs May Hold Key to Treating Pain While Bypassing the Brain (news–2008) http://jama.jamanetwork.com/article.aspx?articleid=182826
Salutary pizza spice (news–2008) http://www.eurekalert.org/pub_releases/2008-06/uob-sps062508.php
Opioids and cannabinoids influence mobility of spermatozoids (news–2008) http://www.alphagalileo.org/ViewItem.aspx?ItemId=5296&CultureCode=en
Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731878/?tool=pmcentrez
The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis (full-2009) http://onlinelibrary.wiley.com/doi/10.1002/art.24395/full
Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855650/?tool=pubmed
Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768535/?tool=pmcentrez
Endocannabinoids and the gastrointestinal tract: what are the key questions? (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190011/
Spatio-temporal expression patterns of anandamide-binding receptors in rat implantation sites: evidence for a role of the endocannabinoid system during the period of placental development (full–2009) http://www.rbej.com/content/7/1/121
The cannabinoid receptor 2 is critical for the host response to sepsis (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763235/?tool=pubmed
CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages (full–2009) http://cardiovascres.oxfordjournals.org/content/84/3/378.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Cannabinoid receptor ligands as potential anticancer agents-high hopes for new therapies? (full–2009) https://d3gqux9sl0z33u.cloudfront.net/AA/AE/gertschgroup/downloads/15931/Oesch___Gertsch_2009.pdf
Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work? (full–2009) http://cardiovascres.oxfordjournals.org/content/84/3/341.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Endocannabinoids and Their Receptors as Targets for Obesity Therapy (full–2009) http://press.endocrine.org/doi/full/10.1210/en.2009-0046?view=long&pmid=19372200
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2 (full–2009) http://www.nature.com/bjc/journal/v101/n6/full/6605248a.html
Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis (full-2009) http://onlinelibrary.wiley.com/doi/10.1002/ibd.20960/full
Endocannabinoid-mediated control of synaptic transmission (full–2009) http://physrev.physiology.org/content/89/1/309.long
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity (full-2009) http://brain.oxfordjournals.org/content/132/11/3152.long
Unconventional neurotransmitters, neurodegeneration and neuroprotection (full–2009) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000100011&lng=en&nrm=iso
The endocannabinoid 2-arachidonoylglycerol promotes sperm developement through activation of cannabinoid-2 receptors (full–2009) http://www.cannabis-med.org/data/pdf/en_2009_04_2_0.pdf
CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319431/
Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington’s disease (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19115380
Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19399401
Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology and potential therapeutic applications (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19897083
Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/20590564
The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi’s sarcoma cells in vitro (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19539619
Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19237169
CXCR4-chemokine receptor and Cannabinoid Receptor 2 (CB2) heterodimerization suggests a mechanism for breast metastasis regulation (abst–2009) http://www.aacrmeetingabstracts.org/cgi/content/meeting_abstract/2009/2_Annual_Meeting/4280?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT
The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19908944
The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19505450?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=18
CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia /reperfusion (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19162037
Synergistic immunopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts (abst–2009) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1234654
Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19409856
The role of CB2 cannabinoid receptor and Leptin in hepatic fibrosis via lymphocyte alterations and HSC phagocytosis (abst–2009) http://www.docstoc.com/docs/76792678/The-role-of-CB2-cannabinoid-receptor-and-Leptin-in-hepatic-
Cough sensors. III. Opioid and cannabinoid receptors on vagal sensory nerves (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/18825336
Intrathecal injection of a Cannabinoid CB2 Receptor Selective Agonist GW405833 Blocks Induction of Allodynia by Sciatic Inflammatory Neuritis (SIN) (abst–2009) http://www.efic-congress.org/showabstract.php?abstract=166
Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19480992
Mode of action of cannabinoids on nociceptive nerve endings (abst–2009) http://www.frontiersin.org/publications/19306092
The cannabinoid system: cannabinoids and receptors (news–2009) http://www.examiner.com/health-science-in-vancouver/the-cannabinoid-system-cannabinoids-andreceptors


CBR-CBe
The quest for a vascular endothelial cannabinoid receptor (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12505689
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor (full–2003) http://molpharm.aspetjournals.org/content/63/3/699.long
G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current (full–2003) http://www.jbc.org/content/278/46/46188.full
The complexities of the cardiovascular actions of cannabinoids (full-2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574918/?tool=pmcentrez
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574972/
Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1 (abst–2004) http://www.sciencedirect.com/science/article/pii/S0014299904001906?np=y
Endogenous Cannabinoid-Like Arachidonoyl Serine Induces Angiogenesis through Novel Pathways (abst–2005) http://abstracts.hematologylibrary.org/cgi/content/abstract/106/11/3690
Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1616976/
Endothelial vasodilatory cannabinoid receptor in the human pulmonary artery: a future option in the therapy of pulmonary hypertension? (link to PDF–2007) http://journals.lww.com/jhypertension/Fulltext/2007/11000/Endothelial_vasodilatory_cannabinoid_receptor_in.4.aspx
Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17921818
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product (full–2008) http://www.ncbi.nlm.nih.gov/pubmed/18806815
Vasoactive and Neuroprotective Actions of a Non-Pyschotropic Atypical Cannabinoid in the Retina (abst–2009) http://iovs.arvojournals.org/article.aspx?articleid=2363001&resultClick=1


CBR-GPR18 / CANNABINOID RECEPTOR
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein coupled receptor GPR18 (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16844083/


CBR-GPR40 / CANNABINOID RECEPTOR / FFAR1
The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16054069
Gpr40 Gene Expression in Human Pancreas and Insulinoma (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16289108
Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751878/?tool=pubmed
Expression of the Gene for a Membrane-bound Fatty Acid Receptor in the Pancreas and Islet Cell Tumours in Humans: Evidence for Gpr40 Expression in Pancreatic Beta Cells and Implications for Insulin Secretion (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16525841
Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose dependent insulin secretion and reduce blood glucose in mice (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494688/?tool=pubmed
Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671040/?tool=pubmed
Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19217448


CBR-GPR55 / CB3 CANNABINOID RECEPTOR
Activated by l-α-lysophosphatidylinositol (LPI), and to a lesser extent possibly by THC, CBD,O-1602, PEA, 2-AG, Anandamide, Virodhamine Cannabinoid Receptor Ligands (full–undated) http://www.tocris.com/pdfs/cannabinoid_receptor_review/page_001.html
Evolutionary Origins of the Endocannabinoid System (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16434153
GPR55: a new member of the cannabinoid receptor clan? (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095104/?tool=pubmed
The orphan receptor GPR55 is a novel cannabinoid receptor (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095107/?tool=pubmed
GPR55 and the vascular receptors for cannabinoids (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190021/?tool=pubmed
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190033/?tool=pubmed
GPR55 and the vascular receptors for cannabinoids (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190021/?tool=pubmed
GPR55 is a novel cannabinoid receptor (full–2007) http://www.biomedcentral.com/1471-2210/7/S2/A3
Novel cannabinoid receptors (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190013/?tool=pmcentrez
CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension induced visceral pain in rodents (full–2007) http://www.jneurosci.org/content/29/5/1554.long
GPR55: signaling pathways and functions (abst–2007) http://www.biomedcentral.com/1471-2210/9/S2/A3
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268199/?tool=pubmed
Interactions of the G protein-coupled receptor-associated sorting proteins (GASP) 1 and 2 with the novel cannabinoid receptor GPR55 (abst–2008) http://www.biomedcentral.com/1471-2210/8/S1/A16
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737440/?tool=pubmed
Receptors for acylethanolamides-GPR55 and GPR119 (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed
Endocannabinoids and the gastrointestinal tract: what are the key questions? (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190011/
Cannabinoid receptor ligands as potential anticancer agents-high hopes for new therapies? (full–2009) https://d3gqux9sl0z33u.cloudfront.net/AA/AE/gertschgroup/downloads/15931/Oesch___Gertsch_2009.pdf
Endocannabinoid-mediated control of synaptic transmission (full–2009) http://physrev.physiology.org/content/89/1/309.long
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation (full–2009) http://www.fasebj.org/content/23/1/183.long
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands (full–2009) http://www.jbc.org/content/284/43/29817.full?sid=ec54c280-2526-4d1b-ab9f-73a1ca683a5e
Receptors for acylethanolamides-GPR55 and GPR119 (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed
Is GPR55 an anandamide receptor? (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19647110
The enigmatic pharmacology of GPR55 (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19233486.
Mode of action of cannabinoids on nociceptive nerve endings (abst–2009) http://www.frontiersin.org/publications/19306092


CBR-GPR119 / CANNABINOID RECEPTOR
A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release (full–2007) http://endo.endojournals.org/content/148/6/2601.long
Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528830/?tool=pubmed
Endocannabinoids and nutrition (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/full
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268073/?tool=pmcentrez
Receptors for acylethanolamides-GPR55 and GPR119 (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/?tool=pubmed
GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671052/?tool=pubmed


CBR-GPR158 / CANNABINOID RECEPTOR
The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers (full–2009) http://onlinelibrary.wiley.com/doi/10.1002/cncr.24394/pdf
top


Advertisements